Immune checkpoint inhibitors for recurrent ovarian clear cell carcinoma: Real-world outcomes from a Korean multicenter study. Chung YE, Kim SI, Noh JJ, Lee JY, et al. Gynecol Oncol 2025;203:185-190.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chung YE, Kim SI, Noh JJ, Lee JY, et al. Immune checkpoint inhibitors for recurrent ovarian clear cell carcinoma: Real-world outcomes from a Korean multicenter study. Gynecol Oncol 2025;203:185-190.
PMID: 41206981